According to a recent LinkedIn post from Vim, the company is drawing attention to a shift in value-based care (VBC) from retrospective to prospective workflows. The post references comments by Chief Business Officer Josh Stern in a brief HIMSS 2026 discussion with Healthcare IT Today, emphasizing delivery of intelligence to providers during the patient visit rather than weeks later.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests that regulatory trends are already encouraging more prospective, point-of-care decision support, which could favor technologies that integrate clinical and financial insights in real time. For investors, this positioning may indicate Vim’s focus on enabling workflow orchestration at the point of care, potentially enhancing its relevance to payers and providers seeking to improve outcomes and manage risk under VBC models.
If Vim can help organizations “close the gap” between data generation and in-visit action, as the post implies, the company could benefit from increased adoption as value-based arrangements expand. This focus on prospective intelligence could also strengthen Vim’s competitive standing within health tech, particularly among platforms aiming to operationalize value-based contracts and influence provider behavior at scale.